Safety and Efficacy of PROMETRIUM® Capsules in Induction of Secretory Conversion
Public ClinicalTrials.gov record NCT00160199. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Evaluation of Safety and Efficacy of PROMETRIUM® Capsules in Induction of Secretory Conversion of Endometrium and Withdrawal Bleeding in Subjects With Secondary Amenorrhea
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
To evaluate the efficacy and safety of 300 mg and 400 mg doses of PROMETRIUM® capsules in women of reproductive age with secondary amenorrhea
Study identification
- NCT ID
- NCT00160199
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 4
- Enrollment
- 240 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 45 Years
- Sex
- Female
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Nov 2004 (Type not available)
- Primary completion
- Feb 2009 (Actual)
- Completion
- Feb 2009 (Actual)
- Last update posted
- Jul 7, 2010
2004 – 2009
United States locations
- U.S. sites
- 42
- U.S. states
- 21
- U.S. cities
- 39
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Site 29 | Mobile | Alabama | — | — |
| Site 41 | Montgomery | Alabama | — | — |
| Site 26 | Tucson | Arizona | — | — |
| Site 5 | Jonesboro | Arkansas | — | — |
| Site 39 | Carmichael | California | — | — |
| Site 17 | Encinitas | California | — | — |
| Site 10 | San Diego | California | — | — |
| Site 42 | Avon | Connecticut | — | — |
| Site 3 | Groton | Connecticut | — | — |
| Site 22 | New Britian | Connecticut | — | — |
| Site 9 | Waterbury | Connecticut | — | — |
| Site 37 | West Hartford | Connecticut | — | — |
| Site 14 | Aventura | Florida | — | — |
| Site 40 | Clearwater | Florida | — | — |
| Site 1 | West Palm Beach | Florida | — | — |
| Site 30 | West Palm Beach | Florida | — | — |
| Site 46 | Atlanta | Georgia | — | — |
| Site 43 | Powder Springs | Georgia | — | — |
| Site 36 | Champaign | Illinois | — | — |
| Site 12 | Chicago | Illinois | — | — |
| Site 6 | Baton Rouge | Louisiana | — | — |
| Site 7 | Baltimore | Maryland | — | — |
| Site 2 | St Louis | Missouri | — | — |
| Site 16 | Reno | Nevada | — | — |
| Site 45 | New York | New York | — | — |
| Site 23 | New Bern | North Carolina | — | — |
| Site 15 | Winston-Salem | North Carolina | — | — |
| Site 28 | Winston-Salem | North Carolina | — | — |
| Site 33 | Cincinnati | Ohio | — | — |
| Site 32 | Erie | Pennsylvania | — | — |
| Site 47 | Hershey | Pennsylvania | — | — |
| Site 44 | Philadelphia | Pennsylvania | — | — |
| Site 38 | Pottstown | Pennsylvania | — | — |
| Site 13 | Greenville | South Carolina | — | — |
| Site 8 | Conroe | Texas | — | — |
| Site 11 | Corpus Christi | Texas | — | — |
| Site 27 | Houston | Texas | — | — |
| Site 34 | Houston | Texas | — | — |
| Site 24 | San Antonio | Texas | — | — |
| Site 35 | Salt Lake City | Utah | — | — |
| Site 19 | Norfolk | Virginia | — | — |
| Site 4 | Seattle | Washington | — | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00160199, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jul 7, 2010 · Synced Oct 23, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00160199 live on ClinicalTrials.gov.